Submitted by Anonymous (not verified) on 7 November 2025 - 11:11
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 1, Status: Authorised